secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001638833-22-000132
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q3 revenue +11% to $620.6M, Adj EBITDA $96.2M, reaffirms FY guidance
--------------------------------------------------------------------------------

- Revenue $620.6M (+11.0% YoY); same-facility revenue +5.1% (cases +3.3%, rev/case +1.8%).
- Net loss $25.0M vs $22.9M loss; Adjusted EBITDA $96.2M (+26% YoY); margin 15.5% (+180bps).
- Reaffirms FY2022 Adj EBITDA $375M-$385M; revenue $2.5-$2.55B.
- YTD deployed $240M on acquisitions (12 facilities) at sub-8x EBITDA; added 150+ physicians.
- Liquidity ~$500M ($154.8M cash + $342M revolver capacity); net debt/EBITDA 6.0x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000132/0001638833-22-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000132/sgry-20221108.htm
  HTML page:      https://secwatch.observer/filing/0001638833-22-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer